United States Biotechnology & Medical Research

ImmuCell Corp (ICCC)

Track

The most recent insider trading activity occurred on December 3, 2025, with President and CEO Paul Francis Olivier te Boekhorst making multiple buy transactions totaling approximately $48,600. Earlier in November 2025, David Scott Tomsche also made several buy transactions. Prior to these, the last recorded insider buy was on June 12, 2025.
Stock chart
Ticker: ICCC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
te Boekhorst Paul Francis Olivier
President and CEO
2 purchases — total 30,536 USD
Buy 3 Dec 2025
Value US$4,045,839.65 | Price 165.88 | Shares 50,992
Buy 3 Dec 2025
Value US$2,116,076.09 | Price 47.85 | Shares 94,655
Buy 2 Dec 2025
Value US$703,990.76 | Price 104.41 | Shares 79,176
Buy 25 Nov 2025
Value US$7,781.24 | Price 4.77 | Shares 1,633
Buy 25 Nov 2025
Value US$7,773.08 | Price 4.76 | Shares 1,633
Buy 12 Jun 2025
Value US$6,320.00 | Price 6.32 | Shares 1,000
Buy 13 Jun 2022
Value US$8,000.00 | Price 8.00 | Shares 1,000
Buy 12 Mar 2020
Value US$8,000.00 | Price 4.00 | Shares 2,000
Buy 11 Mar 2020
Value US$19,688.00 | Price 4.28 | Shares 4,600
Buy 27 Feb 2020
Value US$25,547.40 | Price 4.98 | Shares 5,130
Buy 16 Aug 2018
Value US$20,010.00 | Price 6.67 | Shares 3,000
Buy 27 Jul 2017
Value US$157,500.00 | Price 5.25 | Shares 30,000
Buy 27 Jul 2017
Value US$892,500.00 | Price 5.25 | Shares 170,000
Buy 14 Mar 2017
Value US$2,104.49 | Price 5.41 | Shares 389
Buy 14 Mar 2017
Value US$3,586.10 | Price 5.45 | Shares 658
Buy 14 Mar 2017
Value US$819.00 | Price 5.46 | Shares 150
Buy 13 Mar 2017
Value US$1,705.85 | Price 5.45 | Shares 313
Buy 13 Mar 2017
Value US$2,646.00 | Price 5.40 | Shares 490
Buy 7 Nov 2016
Value US$20,760.00 | Price 5.19 | Shares 4,000
Planned sale 8 Jul 2016
Value US$1,320.00 | Price 6.60 | Shares 200
Sale 8 Jul 2016
Value US$2,596.46 | Price 6.59 | Shares 394
Sale 8 Jul 2016
Value US$3,275.00 | Price 6.55 | Shares 500
Sale 8 Jul 2016
Value US$651.00 | Price 6.51 | Shares 100
Sale 8 Jul 2016
Value US$2,600.00 | Price 6.50 | Shares 400
Sale 8 Jul 2016
Value US$2,226.73 | Price 6.53 | Shares 341
Planned sale 7 Jul 2016
Value US$386.45 | Price 6.55 | Shares 59
Sale 7 Jul 2016
Value US$1,306.00 | Price 6.53 | Shares 200
Sale 7 Jul 2016
Value US$39.54 | Price 6.59 | Shares 6
Sale 6 Jul 2016
Value US$1,977.00 | Price 6.59 | Shares 300
Sale 6 Jul 2016
Value US$2,141.85 | Price 6.57 | Shares 326
Sale 6 Jul 2016
Value US$1,971.00 | Price 6.57 | Shares 300
Sale 6 Jul 2016
Value US$1,974.00 | Price 6.58 | Shares 300
Sale 6 Jul 2016
Value US$1,975.50 | Price 6.59 | Shares 300
Sale 6 Jul 2016
Value US$5,940.00 | Price 6.60 | Shares 900
Planned sale 5 Jul 2016
Value US$662.00 | Price 6.62 | Shares 100
Sale 5 Jul 2016
Value US$656.01 | Price 6.56 | Shares 100
Sale 5 Jul 2016
Value US$8,528.00 | Price 6.56 | Shares 1,300
Sale 5 Jul 2016
Value US$7,260.00 | Price 6.60 | Shares 1,100
Sale 1 Jul 2016
Value US$1,340.00 | Price 6.70 | Shares 200
Sale 1 Jul 2016
Value US$678.50 | Price 6.79 | Shares 100
Sale 1 Jul 2016
Value US$674.00 | Price 6.74 | Shares 100
Sale 1 Jul 2016
Value US$673.50 | Price 6.74 | Shares 100
Sale 1 Jul 2016
Value US$695.50 | Price 6.96 | Shares 100
Sale 1 Jul 2016
Value US$3,465.00 | Price 6.93 | Shares 500
Sale 1 Jul 2016
Value US$1,380.00 | Price 6.90 | Shares 200
Sale 1 Jul 2016
Value US$1,390.00 | Price 6.95 | Shares 200
Sale 1 Jul 2016
Value US$8,280.00 | Price 6.90 | Shares 1,200
Sale 1 Jul 2016
Value US$518.00 | Price 7.00 | Shares 74
Buy 21 Mar 2016
Value US$6,369.85 | Price 6.67 | Shares 955
Buy 29 Jan 2016
Value US$9,996.00 | Price 5.25 | Shares 1,904
Buy 29 Jan 2016
Value US$34,996.50 | Price 5.25 | Shares 6,666
Buy 29 Jan 2016
Value US$14,999.25 | Price 5.25 | Shares 2,857
Buy 29 Jan 2016
Value US$24,995.25 | Price 5.25 | Shares 4,761
Buy 29 Jan 2016
Value US$24,995.25 | Price 5.25 | Shares 4,761
Buy 14 Sep 2015
Value US$1,189.98 | Price 6.80 | Shares 175
Buy 3 Sep 2015
Value US$1,352.00 | Price 6.76 | Shares 200
Buy 2 Sep 2015
Value US$1,354.00 | Price 6.77 | Shares 200
Buy 2 Sep 2015
Value US$3,290.00 | Price 6.58 | Shares 500
Buy 2 Sep 2015
Value US$1,306.00 | Price 6.53 | Shares 200
Buy 2 Sep 2015
Value US$3,250.00 | Price 6.50 | Shares 500
Buy 2 Sep 2015
Value US$1,995.00 | Price 6.65 | Shares 300
Buy 2 Sep 2015
Value US$1,320.00 | Price 6.60 | Shares 200
Buy 2 Sep 2015
Value US$1,296.00 | Price 6.48 | Shares 200
Buy 2 Sep 2015
Value US$1,354.00 | Price 6.77 | Shares 200
Buy 1 Sep 2015
Value US$670.00 | Price 6.70 | Shares 100
Buy 1 Sep 2015
Value US$1,348.00 | Price 6.74 | Shares 200
Buy 1 Sep 2015
Value US$1,346.00 | Price 6.73 | Shares 200
Buy 1 Sep 2015
Value US$6,730.00 | Price 6.73 | Shares 1,000
Buy 31 Aug 2015
Value US$3,585.00 | Price 7.17 | Shares 500
Buy 28 Aug 2015
Value US$10,905.00 | Price 7.27 | Shares 1,500
Buy 28 Aug 2015
Value US$361.50 | Price 7.23 | Shares 50
Buy 28 Aug 2015
Value US$1,089.00 | Price 7.26 | Shares 150
Buy 28 Aug 2015
Value US$1,450.00 | Price 7.25 | Shares 200
Buy 28 Aug 2015
Value US$1,474.00 | Price 7.37 | Shares 200
Buy 28 Aug 2015
Value US$717.00 | Price 7.17 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-03 2025-12-03 B Purchase
3.5
te Boekhorst Paul Francis Olivier

President and CEO

Executive Director
50,992 +3.4%
165.88
US$4,045,840 		50,992 +3.4% 165.88 US$4,045,840
2025-12-03 2025-12-03 B Purchase
3.5
te Boekhorst Paul Francis Olivier

President and CEO

Executive Director
94,655 +19.0%
47.85
US$2,116,076 		94,655 +19.0% 47.85 US$2,116,076
2025-12-03 2025-12-02 B Purchase
3.5
te Boekhorst Paul Francis Olivier

President and CEO

Executive Director
79,176 +4.7%
104.41
US$703,991 		79,176 +4.7% 104.41 US$703,991
2025-11-28 2025-11-25 B Purchase
2.7
Tomsche David Scott
Non-Executive Director
1,633 +52.6%
4.77
US$7,781 		1,633 +52.6% 4.77 US$7,781
2025-11-28 2025-11-25 B Purchase
2.7
Tomsche David Scott
Non-Executive Director
1,633 +3.2%
4.76
US$7,773 		1,633 +3.2% 4.76 US$7,773
2025-06-12 2025-06-12 B Purchase
2.2
Gathagan Bryan K.
Non-Executive Director
1,000 +inf%
6.32
US$6,320 		1,000 +inf% 6.32 US$6,320
2022-06-14 2022-06-13 B Purchase
3.1
Cunningham David
Non-Executive Director
1,000 +6.7%
8.00
US$8,000 		1,000 +6.7% 8.00 US$8,000
2020-03-12 2020-03-12 B Purchase
3.1
Cunningham David
2,000 +15.4%
4.00
US$8,000 		2,000 +15.4% 4.00 US$8,000
2020-03-12 2020-03-11 B Purchase
2.7
Tomsche David Scott
4,600 +5.7%
4.28
US$19,688 		4,600 +5.7% 4.28 US$19,688
2020-03-02 2020-02-27 B Purchase
2.7
Tomsche David Scott
5,130 +6.8%
4.98
US$25,547 		5,130 +6.8% 4.98 US$25,547
2018-08-20 2018-08-16 B Purchase Tomsche David Scott
3,000 +4.1%
6.67
US$20,010 		3,000 +4.1% 6.67 US$20,010
2017-07-28 2017-07-27 B Purchase Pessin Brian L.
30,000 +75.0%
5.25
US$157,500 		30,000 +75.0% 5.25 US$157,500
2017-07-28 2017-07-27 B Purchase PESSIN NORMAN H
170,000 +inf%
5.25
US$892,500 		170,000 +inf% 5.25 US$892,500
2017-03-15 2017-03-14 B Purchase Tomsche David Scott
389 +0.5%
5.41
US$2,104 		389 +0.5% 5.41 US$2,104
2017-03-15 2017-03-14 B Purchase Tomsche David Scott
658 +0.9%
5.45
US$3,586 		658 +0.9% 5.45 US$3,586
2017-03-15 2017-03-14 B Purchase Tomsche David Scott
150 +0.2%
5.46
US$819 		150 +0.2% 5.46 US$819
2017-03-15 2017-03-13 B Purchase Tomsche David Scott
313 +0.4%
5.45
US$1,706 		313 +0.4% 5.45 US$1,706
2017-03-15 2017-03-13 B Purchase Tomsche David Scott
490 +0.7%
5.40
US$2,646 		490 +0.7% 5.40 US$2,646
2016-11-08 2016-11-07 B Purchase Tomsche David Scott Non-Executive Director
4,000 +6.0%
5.19
US$20,760 		4,000 +6.0% 5.19 US$20,760
2016-07-12 2016-07-08 PlS Planned sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
200 -0.2%
6.60
US$1,320 		200 -0.2% 6.60 US$1,320
2016-07-12 2016-07-08 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
394 -0.4%
6.59
US$2,596 		394 -0.4% 6.59 US$2,596
2016-07-12 2016-07-08 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
500 -0.5%
6.55
US$3,275 		500 -0.5% 6.55 US$3,275
2016-07-12 2016-07-08 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
100 -0.1%
6.51
US$651 		100 -0.1% 6.51 US$651
2016-07-12 2016-07-08 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
400 -0.4%
6.50
US$2,600 		400 -0.4% 6.50 US$2,600
2016-07-12 2016-07-08 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
341 -0.3%
6.53
US$2,227 		341 -0.3% 6.53 US$2,227
2016-07-07 2016-07-07 PlS Planned sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
59 -0.1%
6.55
US$386 		59 -0.1% 6.55 US$386
2016-07-07 2016-07-07 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
200 -0.2%
6.53
US$1,306 		200 -0.2% 6.53 US$1,306
2016-07-07 2016-07-07 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
6 -0.0%
6.59
US$40 		6 -0.0% 6.59 US$40
2016-07-07 2016-07-06 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
300 -0.3%
6.59
US$1,977 		300 -0.3% 6.59 US$1,977
2016-07-07 2016-07-06 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
326 -0.3%
6.57
US$2,142 		326 -0.3% 6.57 US$2,142
2016-07-07 2016-07-06 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
300 -0.3%
6.57
US$1,971 		300 -0.3% 6.57 US$1,971
2016-07-07 2016-07-06 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
300 -0.3%
6.58
US$1,974 		300 -0.3% 6.58 US$1,974
2016-07-07 2016-07-06 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
300 -0.3%
6.59
US$1,976 		300 -0.3% 6.59 US$1,976
2016-07-07 2016-07-06 S Sale CRABB JOSEPH H

VP & Chief Scientific Officer

Executive Director
900 -0.8%
6.60
US$5,940 		900 -0.8% 6.60 US$5,940
2016-07-06 2016-07-05 PlS Planned sale CRABB JOSEPH H

Vice President and CSO

Executive Director
100 -0.1%
6.62
US$662 		100 -0.1% 6.62 US$662
2016-07-06 2016-07-05 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
100 -0.1%
6.56
US$656 		100 -0.1% 6.56 US$656
2016-07-06 2016-07-05 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
1,300 -1.2%
6.56
US$8,528 		1,300 -1.2% 6.56 US$8,528
2016-07-06 2016-07-05 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
1,100 -1.0%
6.60
US$7,260 		1,100 -1.0% 6.60 US$7,260
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
200 -0.2%
6.70
US$1,340 		200 -0.2% 6.70 US$1,340
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
100 -0.1%
6.79
US$678 		100 -0.1% 6.79 US$678
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
100 -0.1%
6.74
US$674 		100 -0.1% 6.74 US$674
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
100 -0.1%
6.74
US$674 		100 -0.1% 6.74 US$674
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
100 -0.1%
6.96
US$696 		100 -0.1% 6.96 US$696
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
500 -0.4%
6.93
US$3,465 		500 -0.4% 6.93 US$3,465
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
200 -0.2%
6.90
US$1,380 		200 -0.2% 6.90 US$1,380
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
200 -0.2%
6.95
US$1,390 		200 -0.2% 6.95 US$1,390
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
1,200 -1.0%
6.90
US$8,280 		1,200 -1.0% 6.90 US$8,280
2016-07-06 2016-07-01 S Sale CRABB JOSEPH H

Vice President and CSO

Executive Director
74 -0.1%
7.00
US$518 		74 -0.1% 7.00 US$518
2016-03-22 2016-03-21 B Purchase Tomsche David Scott Non-Executive Director
955 +1.5%
6.67
US$6,370 		955 +1.5% 6.67 US$6,370
2016-02-01 2016-01-29 B Purchase Cunningham David Non-Executive Director
1,904 +34.6%
5.25
US$9,996 		1,904 +34.6% 5.25 US$9,996
2016-02-01 2016-01-29 B Purchase Tomsche David Scott Non-Executive Director
6,666 +11.3%
5.25
US$34,996 		6,666 +11.3% 5.25 US$34,996
2016-02-01 2016-01-29 B Purchase Rhodes Linda Non-Executive Director
2,857 +66.4%
5.25
US$14,999 		2,857 +66.4% 5.25 US$14,999
2016-02-01 2016-01-29 B Purchase ROTHSCHILD JONATHAN E
4,761 +0.9%
5.25
US$24,995 		4,761 +0.9% 5.25 US$24,995
2016-02-01 2016-01-29 B Purchase ROTHSCHILD JONATHAN E
4,761 +1.0%
5.25
US$24,995 		4,761 +1.0% 5.25 US$24,995
2015-09-16 2015-09-14 B Purchase Wainman Paul R Non-Executive Director
175 +9.6%
6.80
US$1,190 		175 +9.6% 6.80 US$1,190
2015-09-03 2015-09-03 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.76
US$1,352 		200 +0.0% 6.76 US$1,352
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.77
US$1,354 		200 +0.0% 6.77 US$1,354
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
500 +0.1%
6.58
US$3,290 		500 +0.1% 6.58 US$3,290
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.53
US$1,306 		200 +0.0% 6.53 US$1,306
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
500 +0.1%
6.50
US$3,250 		500 +0.1% 6.50 US$3,250
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
300 +0.1%
6.65
US$1,995 		300 +0.1% 6.65 US$1,995
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.60
US$1,320 		200 +0.0% 6.60 US$1,320
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.48
US$1,296 		200 +0.0% 6.48 US$1,296
2015-09-03 2015-09-02 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.77
US$1,354 		200 +0.0% 6.77 US$1,354
2015-09-03 2015-09-01 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
100 +0.0%
6.70
US$670 		100 +0.0% 6.70 US$670
2015-09-03 2015-09-01 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.74
US$1,348 		200 +0.0% 6.74 US$1,348
2015-09-03 2015-09-01 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
6.73
US$1,346 		200 +0.0% 6.73 US$1,346
2015-09-03 2015-09-01 B Purchase Tomsche David Scott Non-Executive Director
1,000 +1.7%
6.73
US$6,730 		1,000 +1.7% 6.73 US$6,730
2015-08-31 2015-08-31 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
500 +0.1%
7.17
US$3,585 		500 +0.1% 7.17 US$3,585
2015-09-01 2015-08-28 B Purchase Tomsche David Scott Non-Executive Director
1,500 +2.6%
7.27
US$10,905 		1,500 +2.6% 7.27 US$10,905
2015-08-31 2015-08-28 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
50 +0.0%
7.23
US$362 		50 +0.0% 7.23 US$362
2015-08-31 2015-08-28 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
150 +0.0%
7.26
US$1,089 		150 +0.0% 7.26 US$1,089
2015-08-31 2015-08-28 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
7.25
US$1,450 		200 +0.0% 7.25 US$1,450
2015-08-31 2015-08-28 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
200 +0.0%
7.37
US$1,474 		200 +0.0% 7.37 US$1,474
2015-08-31 2015-08-28 B Purchase ROTHSCHILD JONATHAN E Non-Executive Director Large shareholder
100 +0.0%
7.17
US$717 		100 +0.0% 7.17 US$717
Explore more

More insider trading research around ImmuCell Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America